I subgruppen af patienter med mindst 2 akutte organdysfunktioner ved baseline var mortaliteten 26, 5% i Xigrisgruppen (168 ud af 634) og 33, 9% i placebogruppen (216 ud af 637).
In the subgroup of patients with at least 2 acute organ dysfunctions at baseline, the mortality was 26.5% in the Xigris group (168 out of 634) and 33.9% in the placebo group (216 out of 637).